These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37419331)

  • 41. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.
    Swiątkiewicz M; Zaremba M; Joniec I; Członkowski A; Kurkowska-Jastrzębska I
    Pharmacol Rep; 2013; 65(5):1227-36. PubMed ID: 24399718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of Parkinson's Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson's Disease in Mice.
    Pupyshev AB; Tenditnik MV; Ovsyukova MV; Akopyan AA; Dubrovina NI; Tikhonova MA
    Bull Exp Biol Med; 2021 Aug; 171(4):425-430. PubMed ID: 34542745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
    Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
    Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
    Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
    Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
    Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corydaline alleviates Parkinson's disease by regulating autophagy and GSK-3β phosphorylation.
    Zhou K; Xu S
    Psychopharmacology (Berl); 2024 May; 241(5):1027-1036. PubMed ID: 38289512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice.
    Ye M; Chung HS; Lee C; Hyun Song J; Shim I; Kim YS; Bae H
    Exp Mol Med; 2016 Jul; 48(7):e244. PubMed ID: 27388550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson's Disease Models: A Behavioral and Mechanistic Study.
    Vaidya B; Roy I; Sharma SS
    ACS Chem Neurosci; 2022 Sep; 13(18):2728-2742. PubMed ID: 36094343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease.
    Zhang LF; Yu XL; Ji M; Liu SY; Wu XL; Wang YJ; Liu RT
    Food Funct; 2018 Dec; 9(12):6414-6426. PubMed ID: 30462117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neuroprotective effect of cinnamaldehyde in MPTP-induced mouse model of subacute Parkinson's disease].
    Wu SH; Shi YJ; An YF; Zhao DD; Li HB; Li GL
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6485-6493. PubMed ID: 36604895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice.
    Jang Y; Koo JH; Kwon I; Kang EB; Um HS; Soya H; Lee Y; Cho JY
    Brain Res; 2017 Jan; 1655():186-193. PubMed ID: 27816415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish.
    Ren Q; Jiang X; Paudel YN; Gao X; Gao D; Zhang P; Sheng W; Shang X; Liu K; Zhang X; Jin M
    J Ethnopharmacol; 2022 Jun; 292():115234. PubMed ID: 35358621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.